Susquehanna International Group’s Chembio diagnostics, Inc. CEMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-60,900
Closed -$40K 14914
2022
Q2
$40K Sell
60,900
-25,200
-29% -$16.7K ﹤0.01% 12101
2022
Q1
$71K Sell
86,100
-99,100
-54% -$92.4K ﹤0.01% 12127
2021
Q4
$211K Sell
185,200
-184,400
-50% -$375K ﹤0.01% 11334
2021
Q3
$924K Buy
369,600
+300,200
+433% +$833K ﹤0.01% 7783
2021
Q2
$206K Sell
69,400
-29,200
-30% -$102K ﹤0.01% 11546
2021
Q1
$346K Sell
98,600
-217,700
-69% -$1.21M ﹤0.01% 10321
2020
Q4
$1.5M Buy
316,300
+196,300
+164% +$1.01M ﹤0.01% 5742
2020
Q3
$583K Buy
120,000
+85,700
+250% +$406K ﹤0.01% 7360
2020
Q2
$111K Buy
+34,300
New +$326K ﹤0.01% 9452

Other funds holding CEMI

Susquehanna International Group's CEMI Position: Q1 2023 in Review

Susquehanna International Group sold out of Chembio diagnostics, Inc. (CEMI) in Q1 2023, closing a stake of 56,869 shares — an estimated $12.5K sold.

Susquehanna International Group first reported a position in CEMI in Q2 2020 and held it in 10 quarters. The position peaked at $1.03M in Q4 2020. 30 funds tracked by Wall St. Rank hold CEMI as of Q1 2023.

  • Susquehanna International Group reported no remaining Chembio diagnostics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Susquehanna International Group sold 56,869 Chembio diagnostics, Inc. shares in Q1 2023, an estimated $12.5K.
  • Susquehanna International Group first reported a position in Chembio diagnostics, Inc. in Q2 2020 and held it in 10 quarters.
  • Susquehanna International Group's Chembio diagnostics, Inc. position peaked at $1.03M in Q4 2020.
  • 30 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.